Runway Growth Capital LLC (“Runway”, the “Registrant”, “we”, “our” and “us”) is a Delaware limited liability company that was formed in 2015. Runway is an SEC-registered investment adviser that is controlled, principally owned and led by David R. Spreng. Runway provides investment management services to its advisory clients, which may include privately offered investment funds (“Private Funds”), joint ventures, separately managed accounts (“SMAs”), investment companies registered under the Investment Company Act of 1940, as amended (the “1940 Act”), closed-end management investment companies electing to be regulated as “business development companies” under the 1940 Act (“BDCs” and, together with investment companies registered under the 1940 Act, “1940 Act Funds”), other institutional clients and other types of funds and accounts (collectively, the “Clients”). Our three current Clients are Runway Growth Finance L.P., a private fund (the “Fund”), an SMA (the “Runway SMA”), and a BDC (the “Runway BDC”). Any third-party investors that directly invest in any of our Clients are referred to as “Investors” in this brochure. Our current advisory services are tailored to the needs of our Clients, based on the investment policies and restrictions contained in applicable Client private placement memoranda, articles of incorporation, limited partnership agreements, investment management agreements, and other governing documents (the “Governing Documents”). Clients may impose restrictions or limitations on investing in certain securities or types of securities. We typically invest in what we believe to be high growth-potential, private companies. We primarily originate our own investments in senior secured first-lien term loans and other debt investments. We also invest in equity securities generally acquired in connection with debt financing transactions. We focus on lending to companies in the technology, life sciences, healthcare information and services, business services and other industries we believe have high-growth potential. The technology sectors we focus on include, but may not be limited to, communications, networking, data storage, software, cloud computing, semiconductor, power management, internet and media and consumer-related technologies. The life science sectors we focus on generally include biotechnology, drug discovery, drug delivery, bioinformatics and medical devices. The healthcare information and services sectors we focus on include diagnostics, medical-record services and software and other healthcare-related services and technologies that seek to improve efficiency and quality of administered healthcare. We generally categorize our investments into two strategies: Sponsored Growth Lending and Non-Sponsored Growth Lending. Sponsored Growth Lending. Our Sponsored Growth Lending strategy generally includes loans to private companies that are already backed by established venture capital

and private equity firms. Our Sponsored Growth Lending investments will also typically include the receipt of warrants and/or other equity from these borrowers in connection with our Clients making a loan. We refer to these target borrowers as “venture-backed companies.” We target venture-backed companies at all stages of development, excluding seed stage. Certain companies we invest in may be in the early stages of the revenue growth cycle, and we may invest in certain companies, particularly in the life sciences sector, that are in the pre- revenue stage. To a limited extent, we also selectively lend to publicly traded companies with venture capital ownership. Non-Sponsored Growth Lending. Our Non-Sponsored Growth Lending strategy generally includes loans to fast-growing private companies that are not backed by a professional equity investor sponsor, a venture capital firm or a private equity firm. These companies are funded instead by entrepreneurs themselves and/or no longer require institutional equity investment. We refer to these target borrowers as “non-sponsored growth companies.” As opposed to Sponsored Growth Lending, in the case of Non-Sponsored Growth Lending, we generally target companies with annual revenues of at least $20 million per year, with the exception of certain commercial life science companies. To a limited extent, we also selectively provide non-sponsored growth loans to publicly traded companies. In addition to our core strategies of originating investments in venture-backed companies and non-sponsored growth companies, we may also opportunistically participate in the secondary markets for debt and equity interests in venture-backed companies and non- sponsored growth companies. We do not participate in any wrap fee program. As of December 31, 2023, our regulatory assets under management (“RAUM”) were approximately $1,418,987,297 consisting of approximately $1,069,978,737, and $192,308,560 in total assets of Runway BDC and the Fund, respectively, and $106,700,000 and $50,000,000 in uncalled capital commitments of the Fund, and Runway SMA, respectively. Firm Overview We are controlled and led by David R. Spreng, our founder and Chief Executive Officer. We are supported by a team of dedicated investment, finance, marketing and operations professionals with venture and growth company experience. Our investment team has experience in leveraged lending, including venture lending, as well as private equity investing, and have ongoing working relationships with financial sponsors. Our senior investment professionals have been active participants in the primary and secondary leveraged credit markets throughout their careers. They have managed portfolios of senior loans, subordinated securities, distressed debt, and equity investments as well as other investment types and have managed assets during various stages of economic cycles as well as several market disruptions.